IPP Bureau
LG Chem inks deal with Innovent Biologics for gout treatment candidate
By IPP Bureau - December 15, 2022
LG Chem will receive totaling up to $95.5 million for the China rights
Seeq achieves AWS Life Sciences Competency status
By IPP Bureau - December 15, 2022
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
De Nora and Aclarity sign agreement to deploy PFAS destroying technology
By IPP Bureau - December 15, 2022
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Hovione and GEA collaborate to advance continuous tableting
By IPP Bureau - December 15, 2022
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Balaxi conducts groundbreaking for its Rs 85 crore Hyderabad manufacturing facility
By IPP Bureau - December 14, 2022
The investment will enable the company to enter European markets as well as enhance margins in current markets
AstraZeneca India appoints Dr. Sanjeev Panchal as Country President & MD
By IPP Bureau - December 14, 2022
Sanjeev is currently the Country President for AstraZeneca Malaysia
JB Pharma to buy Glenmark's ‘Razel’ for Rs. 314 crore in India and Nepal
By IPP Bureau - December 14, 2022
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy
BSV receives exclusive marketing and distribution right for NexoBrid in India
By IPP Bureau - December 14, 2022
To focus on providing safer burn treatments for women and armed forces
Peter Bains appointed Additional Director of Biocon
By IPP Bureau - December 13, 2022
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Evonik invests in US based biopharma company ‘Allay Therapeutics’
By IPP Bureau - December 13, 2022
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
US Federal Court dismisses cancer linkage associated with Zantac
By IPP Bureau - December 13, 2022
The current ruling will assure the safety of the use of Ranitidine for Indian patients
European Commission approves SPEVIGO for generalized pustular psoriasis flares
By IPP Bureau - December 13, 2022
EC grants conditional marketing authorization based on the EFFISAYIL trial
Moderna and Merck announce personalized mRNA cancer vaccine
By IPP Bureau - December 13, 2022
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Inclusion of Yoga in the treatment of breast cancer patients is highly beneficial
By IPP Bureau - December 13, 2022
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
Surendran Chemmenkotil to join as CEO of Metropolis Healthcare
By IPP Bureau - December 12, 2022
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
